Which Risk Factors and Colposcopic Patterns Are Predictive for High-Grade VAIN? A Retrospective Analysis.
colposcopic grade
high-grade vaginal intraepithelial neoplasia (VAIN)
papillary lesion
previous hysterectomy for CIN2+
smoking
vascular pattern
Journal
Diagnostics (Basel, Switzerland)
ISSN: 2075-4418
Titre abrégé: Diagnostics (Basel)
Pays: Switzerland
ID NLM: 101658402
Informations de publication
Date de publication:
04 Jan 2023
04 Jan 2023
Historique:
received:
31
10
2022
revised:
24
12
2022
accepted:
30
12
2022
entrez:
21
1
2023
pubmed:
22
1
2023
medline:
22
1
2023
Statut:
epublish
Résumé
Colposcopic patterns of Vaginal Intraepithelial Neoplasia (VAIN) are not definitively related to histological grade. The aim of the present study was to investigate any correlation between clinical and colposcopic features and the development of high-grade VAIN. Two hundred and fifty-five women diagnosed with VAIN (52 VAIN1, 55 VAIN2 and 148 VAIN3) at the European Institute of Oncology, Milan, Italy, from January 2000 to June 2022, were selected for a retrospective analysis. Multivariate logistic regression was performed to estimate the association of risk factors and colposcopic patterns with VAIN grade. Smoking was associated with the development of VAIN (34.1%, p = 0.01). Most women diagnosed with VAIN3 (45.3%, p = 0.02) had a previous history of hysterectomy for CIN2+. At multivariate analysis, colposcopic grade G2 (OR = 20.4, 95%CI: 6.67−61.4, p < 0.001), papillary lesion (OR = 4.33, 95%CI: 1.79−10.5, p = 0.001) and vascularity (OR = 14.4, 95%CI: 1.86−112, p = 0.01) were significantly associated with a greater risk of VAIN3. The risk of high-grade VAIN should not be underestimated in women with a history of smoking and previous hysterectomy for CIN2+, especially when colposcopic findings reveal vaginal lesions characterized by grade 2, papillary and vascular patterns. Accurate diagnosis is crucial for an optimal personalized management, based on risk factors, colposcopic patterns and histologic grade of VAIN.
Identifiants
pubmed: 36672986
pii: diagnostics13020176
doi: 10.3390/diagnostics13020176
pmc: PMC9858341
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Gynecol Oncol. 2001 Nov;83(2):363-9
pubmed: 11606098
BJOG. 2013 Jun;120(7):887-93
pubmed: 23551637
J Low Genit Tract Dis. 2012 Jul;16(3):306-12
pubmed: 22460272
Curr Probl Cancer. 2021 Jun;45(3):100687
pubmed: 33309077
J Obstet Gynaecol Res. 2021 May;47(5):1624-1630
pubmed: 33754436
Eur Rev Med Pharmacol Sci. 2017 Jun;21(12):2823-2828
pubmed: 28682436
Chin Med J (Engl). 2012 Apr;125(7):1219-23
pubmed: 22613591
PLoS One. 2016 Dec 1;11(12):e0167386
pubmed: 27907089
Geburtshilfe Frauenheilkd. 2015 Oct;75(10):1018-1020
pubmed: 26556904
J Gynecol Oncol. 2018 Jan;29(1):e6
pubmed: 29185264
Gynecol Oncol. 2016 Jun;141(3):507-510
pubmed: 27032375
Eur J Cancer Prev. 2018 Mar;27(2):152-157
pubmed: 27428398
BMC Infect Dis. 2011 Jan 11;11:10
pubmed: 21223574
Gynecol Oncol. 2002 Feb;84(2):263-70
pubmed: 11812085
J Obstet Gynaecol Res. 2010 Feb;36(1):94-100
pubmed: 20178533
Arch Gynecol Obstet. 2016 Feb;293(2):415-9
pubmed: 26232937
Int J Cancer. 2008 Jun 15;122(12):2827-34
pubmed: 18348142
Anticancer Res. 2013 Jan;33(1):29-38
pubmed: 23267125
Biomed Res Int. 2018 May 8;2018:5894801
pubmed: 29854768
Acta Obstet Gynecol Scand. 2006;85(9):1114-9
pubmed: 16929418
Cancer Manag Res. 2020 Jul 17;12:5987-5995
pubmed: 32765098
Gynecol Oncol. 2011 Jan;120(1):108-12
pubmed: 20937524
Gynecol Oncol. 2021 Sep;162(3):584-589
pubmed: 34226020
J Low Genit Tract Dis. 2016 Jan;20(1):70-4
pubmed: 26461231
Cancers (Basel). 2021 Jun 29;13(13):
pubmed: 34209851
Cancer Epidemiol Biomarkers Prev. 2008 Jul;17(7):1611-22
pubmed: 18628412
J Low Genit Tract Dis. 2012 Apr;16(2):75-9
pubmed: 22227840
Eur Rev Med Pharmacol Sci. 2016 Mar;20(5):818-24
pubmed: 27010135
Obstet Gynecol. 2012 Jul;120(1):166-72
pubmed: 22914406
Am J Obstet Gynecol. 2013 May;208(5):410.e1-6
pubmed: 23380265
Am J Obstet Gynecol. 2008 Aug;199(2):113.e1-5
pubmed: 18456229
J Low Genit Tract Dis. 2019 Jan;23(1):7-12
pubmed: 30161052
Gynecol Oncol. 2008 Sep;110(3):396-401
pubmed: 18586314
Am J Obstet Gynecol. 1997 Jan;176(1 Pt 1):93-9
pubmed: 9024096
Cancer Manag Res. 2021 Nov 26;13:8855-8863
pubmed: 34858059
Ann Transl Med. 2020 Nov;8(21):1408
pubmed: 33313153
Int J Gynecol Pathol. 2013 Jan;32(1):76-115
pubmed: 23202792